Aurobindo Pharma Market Cap

Aurobindo Pharma has a market cap or net worth of 724.43 billion as of March 9, 2026. Its market cap has increased by 10.25% in one year.

Market Cap

724.43B

Enterprise Value

713.38B

Revenue

331.82B

Ranking

n/a

PE Ratio

20.78

Stock Price

1,247.30

Market Cap Chart

Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 724.43B, an increase of 7,443.61%. That is a compound annual growth rate of 20.01%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	724.43B	5.44%
Dec 31, 2025	687.09B	-11.35%
Dec 31, 2024	775.08B	22.03%
Dec 29, 2023	635.16B	147.32%
Dec 30, 2022	256.82B	-40.31%
Dec 31, 2021	430.28B	-20.29%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Alkem Laboratories	652.82B
Glenmark Pharmaceuticals	597.59B
Mankind Pharma	893.02B
Zydus Lifesciences	914.52B
Laurus Labs	551.19B
Cipla	1,070.31B
Ipca Laboratories	381.22B
Ajanta Pharma	366.72B

Market Cap Rankings